Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harry Alexopoulos

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Nature Reviews. Neurology|October 2, 2020
Complement in neurological disorders and emerging complement-targeted therapeuticsMarinos C Dalakas, Harry Alexopoulos, Peter J Spaeth
Journal of Neurology|March 9, 2011
Paraneoplastic anti-NMDAR encephalitis: long term follow-up reveals persistent serum antibodiesHarry Alexopoulos, Michalis L Kosmidis, Josep Dalmau, et al.
European Journal of Internal Medicine|December 31, 2022
Serological testing for SARS-CoV-2: Advancements and future challengesHarry Alexopoulos, Ioannis P Trougakos, Meletios-Athanasios Dimopoulos, et al.
European Journal of Internal Medicine|November 15, 2022
Clinical usefulness of testing for severe acute respiratory syndrome coronavirus 2 antibodiesHarry Alexopoulos, Ioannis P Trougakos, Meletios-Athanasios Dimopoulos, et al.
Journal of the Neurological Sciences|September 4, 2013
The effect of anakinra, an IL1 receptor antagonist, in patients with sporadic inclusion body myositis (sIBM): a small pilot studyMichalis L Kosmidis, Harry Alexopoulos, Athanasios G Tzioufas, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|October 30, 2015
Immunotherapies for Neurological Manifestations in the Context of Systemic AutoimmunityEleni I Kampylafka, Harry Alexopoulos, Marinos C Dalakas, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 4, 2014
Autoimmune encephalitis with GABAB antibodies, thymoma, and GABAB receptor thymic expressionHarry Alexopoulos, Ioannis E Dagklis, Sofia Akrivou, et al.
Therapeutic Advances in Neurological Disorders|January 21, 2016
Progressive encephalomyelitis with rigidity and myoclonus (PERM): brucellosis as a possible triggering factor and long-term follow-up therapy with rituximabEleni E Magira, Harry Alexopoulos, Evangelos Charitatos, et al.
Annals of Neurology|July 28, 2017
A double-blind, placebo-controlled study of rituximab in patients with stiff person syndromeMarinos C Dalakas, Goran Rakocevic, James M Dambrosia, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 18, 2015
Anti-MOG antibodies are frequently associated with steroid-sensitive recurrent optic neuritisKonstantina Chalmoukou, Harry Alexopoulos, Sofia Akrivou, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Nature Reviews. Neurology|October 2, 2020
Complement in neurological disorders and emerging complement-targeted therapeuticsMarinos C Dalakas, Harry Alexopoulos, Peter J Spaeth
Journal of Neurology|March 9, 2011
Paraneoplastic anti-NMDAR encephalitis: long term follow-up reveals persistent serum antibodiesHarry Alexopoulos, Michalis L Kosmidis, Josep Dalmau, et al.
European Journal of Internal Medicine|December 31, 2022
Serological testing for SARS-CoV-2: Advancements and future challengesHarry Alexopoulos, Ioannis P Trougakos, Meletios-Athanasios Dimopoulos, et al.
European Journal of Internal Medicine|November 15, 2022
Clinical usefulness of testing for severe acute respiratory syndrome coronavirus 2 antibodiesHarry Alexopoulos, Ioannis P Trougakos, Meletios-Athanasios Dimopoulos, et al.
Journal of the Neurological Sciences|September 4, 2013
The effect of anakinra, an IL1 receptor antagonist, in patients with sporadic inclusion body myositis (sIBM): a small pilot studyMichalis L Kosmidis, Harry Alexopoulos, Athanasios G Tzioufas, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|October 30, 2015
Immunotherapies for Neurological Manifestations in the Context of Systemic AutoimmunityEleni I Kampylafka, Harry Alexopoulos, Marinos C Dalakas, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 4, 2014
Autoimmune encephalitis with GABAB antibodies, thymoma, and GABAB receptor thymic expressionHarry Alexopoulos, Ioannis E Dagklis, Sofia Akrivou, et al.
Therapeutic Advances in Neurological Disorders|January 21, 2016
Progressive encephalomyelitis with rigidity and myoclonus (PERM): brucellosis as a possible triggering factor and long-term follow-up therapy with rituximabEleni E Magira, Harry Alexopoulos, Evangelos Charitatos, et al.
Annals of Neurology|July 28, 2017
A double-blind, placebo-controlled study of rituximab in patients with stiff person syndromeMarinos C Dalakas, Goran Rakocevic, James M Dambrosia, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 18, 2015
Anti-MOG antibodies are frequently associated with steroid-sensitive recurrent optic neuritisKonstantina Chalmoukou, Harry Alexopoulos, Sofia Akrivou, et al.
Pageof 4